Pharmabiz

KPRDO demands crackdown on Swiggy Instamart’s 10-minute Medicine Delivery Campaign

KPRDO demands crackdown on Swiggy Instamart’s 10-minute Medicine Delivery Campaign: Nandita Vijayasimha, Bengaluru Wednesday, ...
Pharmabiz

Biogen, Dayra Therapeutics ink collaboration to discover and develop oral macrocyclic peptides for immunological conditions

Biogen, Dayra Therapeutics ink collaboration to discover and develop oral macrocyclic peptides for immunological conditions: Cambridge, Massachusetts Wednesday, November 26, 2025, ...
Pharmabiz

Dr. Lal PathLabs strengthens autoimmune diagnosis with India’s first comprehensive complement lab

Dr. Lal PathLabs (DLPL), one of India’s leading diagnostic networks has launched India’s first dedicated Complement Testing Laboratory, strengthening its position as the country’s leading hub for ...
Pharmabiz

Eris Lifesciences to acquire balance 30% stake in Swiss Parenterals

Eris Lifesciences Limited announced that its board of directors has approved the acquisition of the balance 30% stake in Swiss Parenterals Limited, a subsidiary. The proposed transaction will be ...
Pharmabiz

Abbott initiates medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the US

Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide ...
Pharmabiz

Bristol Myers Squibb gets EC nod to expand use of Breyanzi for relapsed or refractory mantle cell lymphoma

Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell ...
Pharmabiz

Aarthi Scans sets up its second ‘Vital Insights’ Longevity Lab marking the next phase of strategic expansion

Aarthi Scans sets up its second ‘Vital Insights’ Longevity Lab marking the next phase of strategic expansion: Our Bureau, ...
Pharmabiz

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA: Basel Wednesday, November 26, 2025, 09:00 Hrs ...
Pharmabiz

DGFT seeks information from pharma exporters, stakeholders to map pharma export barriers

DGFT seeks information from pharma exporters, stakeholders to map pharma export barriers: Shardul Nautiyal, Mumbai Wednesday, November 26, 2025, 08:00 Hrs [IST] The Directorate Ge ...
Pharmabiz

DGFT streamlines IEC application process for pharma foreign trade with major digital update

DGFT streamlines IEC application process for pharma foreign trade with major digital update: Shardul Nautiyal, Mumbai Wednesday, November 26, 2025, 08:00 Hrs [IST] In order to sim ...
Pharmabiz

Delhi High Court dismisses Artura Pharma's application related to territorial jurisdiction

Delhi High Court dismisses Artura Pharma's application related to territorial jurisdiction: Gireesh Babu, New Delhi Wednesday, November 26, 2025, 08:00 Hrs [IST] The Delhi High Co ...
Pharmabiz

Telangana DCA enforces CDSCO mandate for drug safety reporting

Telangana DCA enforces CDSCO mandate for drug safety reporting: Peethaambaran Kunnathoor, Chennai Wednesday, November 26, 2025, 08:00 Hrs [IST] In a decisive move prioritizing pub ...